Loading...
Loading...
Contributors:
Dataset URI:
90ae5741-76a2-48a0-a84f-2b92e3b80be2The purpose of this study is to compare the efficacy and safety of ESBA1008 versus EYLEA® in the treatment of exudative age-related macular degeneration.
Keyword(s):
Aflibercept; ESBA1008 solution; Exudative age-related macular degeneration; Exudative Age-Related Macular Degeneration.
Grants and Funding:
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)